From biomarker discovery to translational research across many different therapeutical areas including but not limited to oncology, aging, and inflammation, Epigenica’s new EpiFinder™ GenomePro product delivers actionable epigenetic insights in a high-throughput, multiplexed fashion, enabling drug discovery, early diagnosis, monitoring disease progression, and response to treatment.

The kit includes reagents and a detailed protocol for generating sequencing-ready Illumina libraries, yielding up to 24×8=192 quantitative ChIP-seq tracks and corresponding inputs from just 125,000 cells per final ChIP-seq track. A customized analysis pipeline enables an automated analysis workflow from FASTQ to demultiplexed and quantitative data for up to 192 genome-wide profiles, offering in-depth insights into epigenetic studies.

• Low sample volume: 1M cells/multiple epigenetic marks
• Compatible: native and fixed cells, flash frozen tissue
• Flexible: design your custom epigenetic discovery panel
• Bioinformatics support: Automated Open-source data analysis pipeline
• Cost efficient: Industry-leading price unmatched anywhere
• Scalable: Large studies with incomparable speed